Prospective, multicentre, single-arm phase II trial of pembrolizumab combined with carboplatin and pemetrexed in elderly patients with advanced, non-squamous non-small cell lung cancer.
Yuichi OzawaTakeya SugimotoYuichiro AzumaYuhei HarutaniTakanori YoshikawaNobuyuki YamamotoKuninobu KanaiPublished in: BMJ open (2020)
Japan Registry of Clinical Trials (jRCTs051190095).
Keyphrases